Related Experiment Video
Updated: Jun 27, 2026

Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
Methyltransferases in myelodysplastic syndromes: guilty or not guilty?
Abstract:
Hypermethylation of several genes with various functions is frequent in myelodysplastic syndromes (MDS), and has led to the use of demethylating agents in clinical trials. The mechanism of hypermethylation remains unclear, limiting the development of new drugs. Hopfer et al. investigated the role of DNA methyltransferases (DNMTs) during in vitro MDS hematopoietic cell differentiation. They found that different subtypes of DNMTs were associated with different lineages in MDS, and also during normal hematopoiesis, suggesting that DNMTs contribute to aberrant methylation in MDS but are not the cause of this phenomenon.
More Related Videos
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Abnormal Proliferation
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...

